ArticleScientific reports2026
Missing-data-aware machine learning prediction of in-hospital major adverse cardiovascular events after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Machine learning (ML) offers opportunities to improve prognostication after ST-segment elevation myocardial infarction (STEMI), but real-world registries frequently contain incomplete data, and inappropriate handling of missingness may degrade performance. We retrospectively evaluated 659 consecutive STEMI patients undergoing PCI during the index admission. The primary outcome was in-hospital major adverse cardiovascular events (MACE). Eighty clinical, electrocardiographic, laboratory, echocardiographic, and angiographic variables were analyzed, with up to 40% missingness in some predictors. A hybrid feature-selection approach incorporating CatBoost feature importance, SHAP values, variance filtering, and correlation screening identified the most informative predictors. Models were trained using stratified 5-fold cross-validation, comparing native missing-value handling in CatBoost with transformer-based imputation (TabImpute) and a pretrained tabular model (TabPFN). MACE occurred in 282 patients (42.8%). CatBoost trained directly on incompletely observed data achieved the best performance using approximately 8-10 predictors (AUC 0.73), with balanced accuracy 0.69, precision 0.68, and recall 0.53. Transformer-based imputation did not improve discrimination. SHAP analysis indicated that impaired pre-PCI TIMI flow, reduced LVEF, elevated troponin, greater ST-segment deviation, inflammation, and renal dysfunction were the strongest contributors. A class-weighted CatBoost model for in-hospital mortality achieved excellent accuracy (AUC = 0.93). These findings support the use of missing-data-aware ML methods for outcome prediction in STEMI registries and warrant external validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.